ACS CANCER LTD
99-101 DUNSMURE ROAD, LONDON  N16 5HT- Active - Proposal to Strike off
- PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
- Company No. 11667306
- Last Updated: 01 Mar 2024
Company Profile
ACS CANCER LTD was incorporated on Thursday, November 8, 2018 as a PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital) with registered address in LONDON. ACS CANCER LTD has the status: Active - Proposal to Strike off and it's listed in the following category: Physical well-being activities. This PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital) has been operating for 5 years 11 months and 14 days.
Name | ACS CANCER LTD |
---|---|
Company number | 11667306 |
Company type | PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital) |
Incorporation date | 08 Nov 2018 |
Status | Active - Proposal to Strike off |
Industry (SIC 2007) |
Address
Registered Address |
99-101 DUNSMURE ROAD LONDON N16 5HT |
---|---|
Country Of Origin | ENGLAND |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Mr Yisroel Kohn Nationality: British |
Dates: Thursday, November 8, 2018 - present
voting rights 25 to 50 percent
|
Mr Morris Herzog Nationality: British |
Dates: Thursday, November 8, 2018 - present
voting rights 25 to 50 percent
|
Mr Moshe Hersch Kahan Nationality: British |
Dates: Thursday, November 8, 2018 - present
voting rights 25 to 50 percent
|
Accounts and Confirmation
Type of accounts | NO ACCOUNTS FILED |
---|---|
End of financial Year | 30 November |
Next annual accounts due | 08 November 2020, (-1444 days left) |
Latest accounts | Not available |
Next confirmation statement due | 06 December 2019 |
Last confirmation statement dated | Not available |
Mortgages
No mortgages have been registered against ACS CANCER LTD.
Previous Names
Name | Change Date |
---|---|
ACS CANCER LTD | 08 Nov 2018 |